{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:58:53Z","timestamp":1779145133512,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["Z99 CL090055"],"award-info":[{"award-number":["Z99 CL090055"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"National Institutes of Health Clinical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Invasive fungal diseases, such as pulmonary aspergillosis, are common life-threatening infections in immunocompromised patients and effective treatment is often hampered by delays in timely and specific diagnosis. Fungal-specific molecular imaging ligands can provide non-invasive readouts of deep-seated fungal pathologies. In this study, the utility of antibodies and antibody fragments (Fab) targeting \u03b2-glucans in the fungal cell wall to detect Aspergillus infections was evaluated both in vitro and in preclinical mouse models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The binding characteristics of two commercially available \u03b2-glucan antibody clones and their respective antigen-binding Fabs were tested using biolayer interferometry (BLI) assays and immunofluorescence staining. In vivo binding of the Zirconium-89 labeled antibodies\/Fabs to fungal pathogens was then evaluated using PET\/CT imaging in mouse models of fungal infection, bacterial infection and sterile inflammation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One of the evaluated antibodies (HA-\u03b2G-Ab) and its Fab (HA-\u03b2G-Fab) bound to \u03b2-glucans with high affinity (K<jats:sub>D<\/jats:sub>\u2009=\u20090.056 &amp; 21.5\u00a0nM respectively). Binding to the fungal cell wall was validated by immunofluorescence staining and in vitro binding assays. ImmunoPET imaging with intact antibodies however showed slow clearance and high background signal as well as nonspecific accumulation in sites of infection\/inflammation. Conversely, specific binding of [<jats:sup>89<\/jats:sup>Zr]Zr-DFO-HA-\u03b2G-Fab to sites of fungal infection was observed when compared to the isotype control Fab and was significantly higher in fungal infection than in bacterial infection or sterile inflammation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>[<jats:sup>89<\/jats:sup>Zr]Zr-DFO-HA-\u03b2G-Fab can be used to detect fungal infections in vivo. Targeting distinct components of the fungal cell wall is a viable approach to developing fungal-specific PET tracers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00259-024-06760-4","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T04:01:26Z","timestamp":1716523286000},"page":"3223-3234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["PET imaging of Aspergillus infection using Zirconium-89 labeled anti-\u03b2-glucan antibody fragments"],"prefix":"10.1007","volume":"51","author":[{"given":"Jianhao","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neysha","family":"Martinez-Orengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekeya","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyob","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lyndaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falguni","family":"Basuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-7871","authenticated-orcid":false,"given":"Dima A.","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"6760_CR1","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3389\/fimmu.2019.01524","volume":"10","author":"Z Li","year":"2019","unstructured":"Li Z, Lu G, Meng G. Pathogenic Fungal Infection in the Lung. Front Immunol. 2019;10:1524. https:\/\/doi.org\/10.3389\/fimmu.2019.01524.","journal-title":"Front Immunol"},{"key":"6760_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/MOP.0000000000000031","volume":"25","author":"F Lanternier","year":"2013","unstructured":"Lanternier F, Cypowyj S, Picard C, Bustamante J, Lortholary O, Casanova JL, et al. Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr. 2013;25:736\u201347. https:\/\/doi.org\/10.1097\/MOP.0000000000000031.","journal-title":"Curr Opin Pediatr"},{"key":"6760_CR3","doi-asserted-by":"publisher","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017;3. https:\/\/doi.org\/10.3390\/jof3040057.","DOI":"10.3390\/jof3040057"},{"key":"6760_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMra0808853","volume":"360","author":"BH Segal","year":"2009","unstructured":"Segal BH. Aspergillosis. N Engl J Med. 2009;360:1870\u201384. https:\/\/doi.org\/10.1056\/NEJMra0808853.","journal-title":"N Engl J Med"},{"key":"6760_CR5","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1093\/infdis\/jiad067","volume":"228","author":"J Lai","year":"2023","unstructured":"Lai J, Wang B, Petrik M, Beziere N, Hammoud DA. Radiotracer development for fungal-specific imaging: past, present, and future. J Infect Dis. 2023;228:S259\u201369. https:\/\/doi.org\/10.1093\/infdis\/jiad067.","journal-title":"J Infect Dis"},{"key":"6760_CR6","doi-asserted-by":"publisher","unstructured":"Gow NAR, Latge JP, Munro CA. The fungal cell wall: structure, biosynthesis, and function. Microbiol Spectr. 2017;5. https:\/\/doi.org\/10.1128\/microbiolspec.FUNK-0035-2016.","DOI":"10.1128\/microbiolspec.FUNK-0035-2016"},{"key":"6760_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2958.2007.05872.x","volume":"66","author":"JP Latge","year":"2007","unstructured":"Latge JP. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol. 2007;66:279\u201390. https:\/\/doi.org\/10.1111\/j.1365-2958.2007.05872.x.","journal-title":"Mol Microbiol"},{"key":"6760_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/cid\/ciq206","volume":"52","author":"DE Karageorgopoulos","year":"2011","unstructured":"Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. beta-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis. 2011;52:750\u201370. https:\/\/doi.org\/10.1093\/cid\/ciq206.","journal-title":"Clin Infect Dis"},{"key":"6760_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1309\/lm8bw8qnv7nzbrog","volume":"42","author":"WF Wright","year":"2011","unstructured":"Wright WF, Overman SB, Ribes JA. (1\u20133)-\u03b2-D-Glucan assay: a review of its laboratory and clinical application. Lab Med. 2011;42:679\u201385. https:\/\/doi.org\/10.1309\/lm8bw8qnv7nzbrog.","journal-title":"Lab Med"},{"key":"6760_CR10","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2967\/jnumed.122.265172","volume":"64","author":"EL Brown","year":"2023","unstructured":"Brown EL, Shmuel S, Mandleywala K, Panikar SS, Berry NK, Rao Y, et al. Immuno-PET detects antibody-drug potency on coadministration with statins. J Nucl Med. 2023;64:1638\u201346. https:\/\/doi.org\/10.2967\/jnumed.122.265172.","journal-title":"J Nucl Med"},{"key":"6760_CR11","doi-asserted-by":"publisher","unstructured":"Yeh R, O'Donoghue JA, Jayaprakasam VS, Mauguen A, Min R, Park S, et al. First-in-human evaluation of site-specifically labeled (89)Zr-Pertuzumab in patients with HER2-positive breast cancer. J Nucl Med. 2024. https:\/\/doi.org\/10.2967\/jnumed.123.266392.","DOI":"10.2967\/jnumed.123.266392"},{"key":"6760_CR12","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/s41467-021-21965-z","volume":"12","author":"S Henneberg","year":"2021","unstructured":"Henneberg S, Hasenberg A, Maurer A, Neumann F, Bornemann L, Gonzalez-Menendez I, et al. Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatment. Nat Commun. 2021;12:1707. https:\/\/doi.org\/10.1038\/s41467-021-21965-z.","journal-title":"Nat Commun"},{"key":"6760_CR13","doi-asserted-by":"publisher","unstructured":"Schwenck J, Maurer A, Beziere N, Fiz F, Boschetti F, Geistlich S, et al. Antibody-guided molecular imaging of aspergillus lung infections in leukemia patients. J Nucl Med. 2022. https:\/\/doi.org\/10.2967\/jnumed.121.263251.","DOI":"10.2967\/jnumed.121.263251"},{"key":"6760_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2967\/jnumed.122.263861","volume":"63","author":"C Rodriguez","year":"2022","unstructured":"Rodriguez C, Delaney S, Sarrett SM, Kein\u00e4nen OM, Zeglis BM. Antibody engineering for nuclear imaging and radioimmunotherapy. J Nucl Med. 2022;63:1316\u201322. https:\/\/doi.org\/10.2967\/jnumed.122.263861.","journal-title":"J Nucl Med"},{"key":"6760_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jac\/dks379","volume":"68","author":"EA Azzopardi","year":"2013","unstructured":"Azzopardi EA, Ferguson EL, Thomas DW. The enhanced permeability retention effect: a new paradigm for drug targeting in infection. J Antimicrob Chemother. 2013;68:257\u201374. https:\/\/doi.org\/10.1093\/jac\/dks379.","journal-title":"J Antimicrob Chemother"},{"key":"6760_CR16","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1084\/jem.170.6.2153","volume":"170","author":"M Bruggemann","year":"1989","unstructured":"Bruggemann M, Winter G, Waldmann H, Neuberger MS. The immunogenicity of chimeric antibodies. J Exp Med. 1989;170:2153\u20137. https:\/\/doi.org\/10.1084\/jem.170.6.2153.","journal-title":"J Exp Med"},{"key":"6760_CR17","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00259-015-3038-1","volume":"42","author":"S Shi","year":"2015","unstructured":"Shi S, Hong H, Orbay H, Graves SA, Yang Y, Ohman JD, et al. ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment. Eur J Nucl Med Mol Imaging. 2015;42:1295\u2013303. https:\/\/doi.org\/10.1007\/s00259-015-3038-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6760_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nprot.2010.13","volume":"5","author":"MJ Vosjan","year":"2010","unstructured":"Vosjan MJ, Perk LR, Visser GW, Budde M, Jurek P, Kiefer GE, et al. Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine. Nat Protoc. 2010;5:739\u201343. https:\/\/doi.org\/10.1038\/nprot.2010.13.","journal-title":"Nat Protoc"},{"key":"6760_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/3499655","volume":"2023","author":"EM Jagoda","year":"2023","unstructured":"Jagoda EM, Basuli F, Olkowski C, Weiss I, Phelps TE, Wong K, et al. Immuno-PET imaging of Siglec-15 using the Zirconium-89-Labeled therapeutic antibody, NC318. Mol Imaging. 2023;2023:1\u201318. https:\/\/doi.org\/10.1155\/2023\/3499655.","journal-title":"Mol Imaging"},{"key":"6760_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1021\/bc9003603","volume":"21","author":"Z Liu","year":"2010","unstructured":"Liu Z, Jin C, Yu Z, Zhang J, Liu Y, Zhao H, et al. Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody. Bioconjug Chem. 2010;21:314\u20138. https:\/\/doi.org\/10.1021\/bc9003603.","journal-title":"Bioconjug Chem"},{"key":"6760_CR21","doi-asserted-by":"publisher","unstructured":"Lai J, Shah S, Knight R, Martinez-Orengo N, Patel R, Mitchell A, et al. Evaluation of 2-[18F]-Fluorodeoxysorbitol PET imaging in preclinical models of Aspergillus infection. J Fungi. 2021;8. https:\/\/doi.org\/10.3390\/jof8010025.","DOI":"10.3390\/jof8010025"},{"key":"6760_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2165\/00002018-200427140-00004","volume":"27","author":"RJ Flanagan","year":"2004","unstructured":"Flanagan RJ, Jones AL. Fab antibody fragments: some applications in clinical toxicology. Drug Saf. 2004;27:1115\u201333. https:\/\/doi.org\/10.2165\/00002018-200427140-00004.","journal-title":"Drug Saf"},{"key":"6760_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/eji.1830180221","volume":"18","author":"P Vieira","year":"1988","unstructured":"Vieira P, Rajewsky K. The half-lives of serum immunoglobulins in adult mice. Eur J Immunol. 1988;18:313\u20136. https:\/\/doi.org\/10.1002\/eji.1830180221.","journal-title":"Eur J Immunol"},{"key":"6760_CR24","doi-asserted-by":"publisher","first-page":"1285117","DOI":"10.3389\/fonc.2023.1285117","volume":"13","author":"JB Hackett","year":"2023","unstructured":"Hackett JB, Ramos N, Barr S, Bross M, Viola NT, Gibson HM. Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors. Front Oncol. 2023;13:1285117. https:\/\/doi.org\/10.3389\/fonc.2023.1285117.","journal-title":"Front Oncol"},{"key":"6760_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s13139-020-00638-7","volume":"54","author":"A Richter","year":"2020","unstructured":"Richter A, Knorr K, Schlapschy M, Robu S, Morath V, Mendler C, et al. First in-human medical imaging with a PASylated (89)Zr-labeled anti-HER2 Fab-fragment in a patient with metastatic breast cancer. Nucl Med Mol Imaging. 2020;54:114\u20139. https:\/\/doi.org\/10.1007\/s13139-020-00638-7.","journal-title":"Nucl Med Mol Imaging"},{"key":"6760_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-1-1","volume":"1","author":"KJ Wong","year":"2011","unstructured":"Wong KJ, Baidoo KE, Nayak TK, Garmestani K, Brechbiel MW, Milenic DE. In vitro and in vivo pre-clinical analysis of a F(ab\u2019)(2) fragment of panitumumab for molecular imaging and therapy of HER1 positive cancers. EJNMMI Res. 2011;1:1. https:\/\/doi.org\/10.1186\/2191-219X-1-1.","journal-title":"EJNMMI Res"},{"key":"6760_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/19420862.2015.1111497","volume":"8","author":"Z Li","year":"2016","unstructured":"Li Z, Krippendorff BF, Sharma S, Walz AC, Lave T, Shah DK. Influence of molecular size on tissue distribution of antibody fragments. MAbs. 2016;8:113\u20139. https:\/\/doi.org\/10.1080\/19420862.2015.1111497.","journal-title":"MAbs"},{"key":"6760_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-micro-030117-020406","volume":"71","author":"JP Latge","year":"2017","unstructured":"Latge JP, Beauvais A, Chamilos G. The cell wall of the human fungal pathogen aspergillus fumigatus: biosynthesis, organization, immune response, and virulence. Annu Rev Microbiol. 2017;71:99\u2013116. https:\/\/doi.org\/10.1146\/annurev-micro-030117-020406.","journal-title":"Annu Rev Microbiol"},{"key":"6760_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1056\/NEJM198910053211404","volume":"321","author":"RH Rubin","year":"1989","unstructured":"Rubin RH, Fischman AJ, Callahan RJ, Khaw BA, Keech F, Ahmad M, et al. 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med. 1989;321:935\u201340. https:\/\/doi.org\/10.1056\/NEJM198910053211404.","journal-title":"N Engl J Med"},{"key":"6760_CR30","first-page":"2066","volume":"40","author":"ET Dams","year":"1999","unstructured":"Dams ET, Becker MJ, Oyen WJ, Boerman OC, Storm G, Laverman P, et al. Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. J Nucl Med. 1999;40:2066\u201372.","journal-title":"J Nucl Med"},{"key":"6760_CR31","first-page":"1199","volume":"31","author":"AJ Fischman","year":"1990","unstructured":"Fischman AJ, Rubin RH, White JA, Locke E, Wilkinson RA, Nedelman M, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med. 1990;31:1199\u2013205.","journal-title":"J Nucl Med"},{"key":"6760_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3389\/fimmu.2019.00811","volume":"10","author":"S Ben Mkaddem","year":"2019","unstructured":"Ben Mkaddem S, Benhamou M, Monteiro RC. Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools. Front Immunol. 2019;10:811. https:\/\/doi.org\/10.3389\/fimmu.2019.00811.","journal-title":"Front Immunol"},{"key":"6760_CR33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2503","author":"EC Piccione","year":"2016","unstructured":"Piccione EC, Juarez S, Tseng S, Liu J, Stafford M, Narayanan C, et al. SIRPalpha-antibody fusion proteins selectively bind and eliminate dual antigen-expressing tumor cells. Clin Cancer Res. 2016. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2503.","journal-title":"Clin Cancer Res"},{"key":"6760_CR34","first-page":"278","volume":"78","author":"N Yousaf","year":"1989","unstructured":"Yousaf N, Howard JC, Williams BD. Demonstration of hepatic Fc receptor function in vivo. Clin Exp Immunol. 1989;78:278\u201384.","journal-title":"Clin Exp Immunol"},{"key":"6760_CR35","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1074\/jbc.M116.770628","volume":"292","author":"S Kasturirangan","year":"2017","unstructured":"Kasturirangan S, Rainey GJ, Xu L, Wang X, Portnoff A, Chen T, et al. Targeted Fcgamma receptor (FcgammaR)-mediated clearance by a biparatopic bispecific antibody. J Biol Chem. 2017;292:4361\u201370. https:\/\/doi.org\/10.1074\/jbc.M116.770628.","journal-title":"J Biol Chem"},{"key":"6760_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nature08264","volume":"460","author":"V Aimanianda","year":"2009","unstructured":"Aimanianda V, Bayry J, Bozza S, Kniemeyer O, Perruccio K, Elluru SR, et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature. 2009;460:1117\u201321. https:\/\/doi.org\/10.1038\/nature08264.","journal-title":"Nature"},{"key":"6760_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","volume":"202","author":"A Torosantucci","year":"2005","unstructured":"Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, Galli C, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med. 2005;202:597\u2013606. https:\/\/doi.org\/10.1084\/jem.20050749.","journal-title":"J Exp Med"},{"key":"6760_CR38","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1371\/journal.ppat.0010030","volume":"1","author":"TM Hohl","year":"2005","unstructured":"Hohl TM, Van Epps HL, Rivera A, Morgan LA, Chen PL, Feldmesser M, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 2005;1:e30. https:\/\/doi.org\/10.1371\/journal.ppat.0010030.","journal-title":"PLoS Pathog"},{"key":"6760_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","volume":"15","author":"FL van de Veerdonk","year":"2017","unstructured":"van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latge JP. Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol. 2017;15:661\u201374. https:\/\/doi.org\/10.1038\/nrmicro.2017.90.","journal-title":"Nat Rev Microbiol"},{"key":"6760_CR40","doi-asserted-by":"publisher","unstructured":"Bontemps-Gallo S, Bohin JP, Lacroix JM. Osmoregulated periplasmic glucans. EcoSal Plus. 2017;7. https:\/\/doi.org\/10.1128\/ecosalplus.ESP-0001-2017.","DOI":"10.1128\/ecosalplus.ESP-0001-2017"},{"key":"6760_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jmb.2004.07.004","volume":"342","author":"X Hanoulle","year":"2004","unstructured":"Hanoulle X, Rollet E, Clantin B, Landrieu I, Odberg-Ferragut C, Lippens G, et al. Structural analysis of Escherichia coli OpgG, a protein required for the biosynthesis of osmoregulated periplasmic glucans. J Mol Biol. 2004;342:195\u2013205. https:\/\/doi.org\/10.1016\/j.jmb.2004.07.004.","journal-title":"J Mol Biol"},{"key":"6760_CR42","doi-asserted-by":"publisher","unstructured":"Chang SC, Saldivar RK, Liang PH, Hsieh YSY. Structures, biosynthesis, and physiological functions of (1,3;1,4)-beta-D-Glucans. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10030510.","DOI":"10.3390\/cells10030510"},{"key":"6760_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.semnuclmed.2009.12.005","volume":"40","author":"T Olafsen","year":"2010","unstructured":"Olafsen T, Wu AM. Antibody vectors for imaging. Semin Nucl Med. 2010;40:167\u201381. https:\/\/doi.org\/10.1053\/j.semnuclmed.2009.12.005.","journal-title":"Semin Nucl Med"},{"key":"6760_CR44","doi-asserted-by":"publisher","unstructured":"de Roode KE, Joosten L, Behe M. Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands. Pharmaceuticals (Basel). 2024;17. https:\/\/doi.org\/10.3390\/ph17020256.","DOI":"10.3390\/ph17020256"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06760-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T18:03:31Z","timestamp":1725300211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06760-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["6760"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06760-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"24 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures, including handling and care of the animals, were performed in an AAALAC International accredited facility in accordance with relevant NIH policies and the Animal Welfare Act and Regulations and were approved by the Animal Care and Use Committee of the Clinical Center of the NIH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}